Urine Metabolomics Reveals the Intervention Effects and Mechanism of Shenhua Tablets in IgA Nephropathy
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Yuhang Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National TC…. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Drugs, Chinese Herbal, Metabolomics, Metabolome. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Heilongjiang Provincial Key Research and Development Program.
Abstract (Originalsprache)
Shenhua tablets (SHT), a traditional Chinese medicine (TCM), have shown significant clinical efficacy in treating IgA nephropathy (IgAN), but the underlying mechanisms are not fully understood. This study aims to elucidate the renoprotective effects of SHT on IgAN and explore the potential mechanisms of its action using metabolomics approaches. The renoprotective effects of SHT on IgAN were evaluated in a Thy‐1 antibody‐induced IgAN rat model. Metabolomics techniques were employed to detect and analyze urine biomarkers of IgAN, and to identify SHT targets and metabolic pathways. SHT significantly reduced the levels of 24‐h urine protein (Upro), albumin‐to‐creatinine ratio (ACR), Interleukin 1β (IL‐1β), tumor necrosis factor‐α (TNF‐α), and interleukin 6 (IL‐6), alleviated kidney tissue damage, and inhibited mesangial cell proliferation. Seventeen urine metabolites were identified as biomarkers for IgAN, 14 of which were restored by SHT. SHT primarily modulated metabolic pathways, including the tricarboxylic acid (TCA) cycle, glycolysis/gluconeogenesis, pyruvate metabolism, and β‐alanine metabolism, upregulating citric acid and succinic acid while downregulating pyruvic acid, L‐lactic acid, uracil, and malonic semialdehyde. SHT exerts renoprotective effects in IgAN by modulating key metabolic pathways and normalizing abnormal metabolites levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory,…
- Department of Nephrology First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center…
ORCID-Profile: Yuhang Wang
Förderung
- National Natural Science Foundation of China
- Heilongjiang Provincial Key Research and Development Program
Zitieren
APA
Wang, Y., Li, P., Yin, F., Zheng, Y., Liu, H., Sun, H., Wang, M., Liu, C., Chen, X., Yan, G., Yan, X., Hu, Y., Guan, S., & Wang, X. (2025). Urine Metabolomics Reveals the Intervention Effects and Mechanism of Shenhua Tablets in IgA Nephropathy. Biomedical Chromatography. https://doi.org/10.1002/bmc.70078
Vancouver
Wang Y, Li P, Yin F, Zheng Y, Liu H, Sun H, et al. Urine Metabolomics Reveals the Intervention Effects and Mechanism of Shenhua Tablets in IgA Nephropathy. Biomedical Chromatography. 2025. doi:10.1002/bmc.70078
BibTeX
@article{Wang2025,
author = {Wang, Yuhang and Li, Ping and Yin, Fengting and Zheng, Ying and Liu, Huiqiang and Sun, Hui and Wang, Mengmeng and Liu, Chang and Chen, Xiangmei and Yan, Guangli and Yan, Xiaotong and Hu, Yu and Guan, Shihan and Wang, Xijun},
title = {Urine Metabolomics Reveals the Intervention Effects and Mechanism of Shenhua Tablets in IgA Nephropathy},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70078}
}
EUVIMED